Compare CYRX & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYRX | SAR |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 472.7M | 369.9M |
| IPO Year | N/A | 2007 |
| Metric | CYRX | SAR |
|---|---|---|
| Price | $10.06 | $23.24 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 4 |
| Target Price | $12.83 | ★ $23.75 |
| AVG Volume (30 Days) | ★ 441.3K | 87.7K |
| Earning Date | 11-04-2025 | 01-07-2026 |
| Dividend Yield | N/A | ★ 12.94% |
| EPS Growth | N/A | ★ 52.15 |
| EPS | 1.27 | ★ 2.38 |
| Revenue | ★ $243,795,000.00 | $130,118,086.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.26 | $1.28 |
| P/E Ratio | ★ $7.92 | $9.73 |
| Revenue Growth | ★ 41.27 | N/A |
| 52 Week Low | $4.58 | $21.10 |
| 52 Week High | $11.44 | $26.17 |
| Indicator | CYRX | SAR |
|---|---|---|
| Relative Strength Index (RSI) | 61.81 | 54.88 |
| Support Level | $9.44 | $22.97 |
| Resistance Level | $9.87 | $23.64 |
| Average True Range (ATR) | 0.33 | 0.28 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 85.96 | 46.65 |
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.